vs
Biofrontera Inc.（BFRI）与Digimarc CORP（DMRC）财务数据对比。点击上方公司名可切换其他公司
Biofrontera Inc.的季度营收约是Digimarc CORP的1.9倍（$17.1M vs $8.9M），Biofrontera Inc.净利率更高（33.0% vs -47.2%，领先80.2%），Biofrontera Inc.同比增速更快（36.2% vs 2.9%），Digimarc CORP自由现金流更多（$895.0K vs $-2.4M），过去两年Biofrontera Inc.的营收复合增速更高（47.0% vs -5.3%）
Biofrontera Inc.是一家专注于皮肤病治疗领域的特种生物制药企业，主要研发和商业化处方类皮肤科药物，核心产品线针对光化性角化病等常见皮肤病症，主要市场覆盖美国及欧盟地区，服务皮肤科医护人员与患者。
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
BFRI vs DMRC — 直观对比
营收规模更大
BFRI
是对方的1.9倍
$8.9M
营收增速更快
BFRI
高出33.3%
2.9%
净利率更高
BFRI
高出80.2%
-47.2%
自由现金流更多
DMRC
多$3.3M
$-2.4M
两年增速更快
BFRI
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $17.1M | $8.9M |
| 净利润 | $5.6M | $-4.2M |
| 毛利率 | — | 63.5% |
| 营业利润率 | 26.6% | -48.2% |
| 净利率 | 33.0% | -47.2% |
| 营收同比 | 36.2% | 2.9% |
| 净利润同比 | 504.0% | 51.4% |
| 每股收益（稀释后） | $0.62 | $-0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BFRIDMRC
| Q4 25 | $17.1M | $8.9M | ||
| Q3 25 | $7.0M | $7.6M | ||
| Q2 25 | $9.0M | $8.0M | ||
| Q1 25 | $8.6M | $9.4M | ||
| Q4 24 | $12.6M | $8.7M | ||
| Q3 24 | $9.0M | $9.4M | ||
| Q2 24 | $7.8M | $10.4M | ||
| Q1 24 | $7.9M | $9.9M |
净利润BFRIDMRC
| Q4 25 | $5.6M | $-4.2M | ||
| Q3 25 | $-6.6M | $-8.2M | ||
| Q2 25 | $-5.3M | $-8.2M | ||
| Q1 25 | $-4.2M | $-11.7M | ||
| Q4 24 | $-1.4M | $-8.6M | ||
| Q3 24 | $-5.7M | $-10.8M | ||
| Q2 24 | $-257.0K | $-9.3M | ||
| Q1 24 | $-10.4M | $-10.3M |
毛利率BFRIDMRC
| Q4 25 | — | 63.5% | ||
| Q3 25 | — | 58.3% | ||
| Q2 25 | — | 58.8% | ||
| Q1 25 | — | 65.0% | ||
| Q4 24 | — | 60.8% | ||
| Q3 24 | — | 62.4% | ||
| Q2 24 | — | 66.1% | ||
| Q1 24 | — | 62.5% |
营业利润率BFRIDMRC
| Q4 25 | 26.6% | -48.2% | ||
| Q3 25 | -89.8% | -109.7% | ||
| Q2 25 | -56.2% | -105.2% | ||
| Q1 25 | -52.9% | -128.9% | ||
| Q4 24 | -13.6% | -105.1% | ||
| Q3 24 | -55.0% | -120.4% | ||
| Q2 24 | -64.7% | -96.2% | ||
| Q1 24 | -69.1% | -109.2% |
净利率BFRIDMRC
| Q4 25 | 33.0% | -47.2% | ||
| Q3 25 | -95.1% | -106.9% | ||
| Q2 25 | -59.0% | -102.6% | ||
| Q1 25 | -48.9% | -125.2% | ||
| Q4 24 | -11.1% | -99.9% | ||
| Q3 24 | -62.9% | -113.9% | ||
| Q2 24 | -3.3% | -89.3% | ||
| Q1 24 | -131.9% | -104.0% |
每股收益（稀释后）BFRIDMRC
| Q4 25 | $0.62 | $-0.18 | ||
| Q3 25 | $-0.62 | $-0.38 | ||
| Q2 25 | $-0.57 | $-0.38 | ||
| Q1 25 | $-0.47 | $-0.55 | ||
| Q4 24 | $0.69 | $-0.40 | ||
| Q3 24 | $-0.98 | $-0.50 | ||
| Q2 24 | $-0.05 | $-0.43 | ||
| Q1 24 | $-2.88 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.4M | $12.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $10.5M | $40.2M |
| 总资产 | $28.6M | $53.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BFRIDMRC
| Q4 25 | $6.4M | $12.9M | ||
| Q3 25 | $3.4M | $12.6M | ||
| Q2 25 | $7.2M | $16.1M | ||
| Q1 25 | $1.8M | $21.6M | ||
| Q4 24 | $5.9M | $28.7M | ||
| Q3 24 | $2.9M | $33.7M | ||
| Q2 24 | $4.4M | $41.5M | ||
| Q1 24 | $3.8M | $48.9M |
股东权益BFRIDMRC
| Q4 25 | $10.5M | $40.2M | ||
| Q3 25 | $-2.6M | $41.4M | ||
| Q2 25 | $-4.7M | $46.5M | ||
| Q1 25 | $500.0K | $50.0M | ||
| Q4 24 | $4.4M | $61.4M | ||
| Q3 24 | $5.5M | $70.2M | ||
| Q2 24 | $10.9M | $77.2M | ||
| Q1 24 | $-5.4M | $84.5M |
总资产BFRIDMRC
| Q4 25 | $28.6M | $53.0M | ||
| Q3 25 | $15.4M | $55.4M | ||
| Q2 25 | $20.1M | $60.7M | ||
| Q1 25 | $16.6M | $66.5M | ||
| Q4 24 | $22.1M | $75.8M | ||
| Q3 24 | $18.5M | $85.0M | ||
| Q2 24 | $21.6M | $93.4M | ||
| Q1 24 | $24.6M | $99.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.4M | $991.0K |
| 自由现金流经营现金流 - 资本支出 | $-2.4M | $895.0K |
| 自由现金流率自由现金流/营收 | -13.9% | 10.0% |
| 资本支出强度资本支出/营收 | 0.0% | 1.1% |
| 现金转化率经营现金流/净利润 | -0.42× | — |
| 过去12个月自由现金流最近4个季度 | $-13.4M | $-12.3M |
8季度趋势，按日历期对齐
经营现金流BFRIDMRC
| Q4 25 | $-2.4M | $991.0K | ||
| Q3 25 | $-3.8M | $-2.6M | ||
| Q2 25 | $-3.0M | $-4.7M | ||
| Q1 25 | $-4.1M | $-5.5M | ||
| Q4 24 | $-1.0M | $-4.2M | ||
| Q3 24 | $-1.2M | $-7.1M | ||
| Q2 24 | $-4.7M | $-6.8M | ||
| Q1 24 | $-3.3M | $-8.4M |
自由现金流BFRIDMRC
| Q4 25 | $-2.4M | $895.0K | ||
| Q3 25 | $-3.8M | $-2.8M | ||
| Q2 25 | $-3.0M | $-4.9M | ||
| Q1 25 | $-4.1M | $-5.5M | ||
| Q4 24 | $-1.0M | $-4.2M | ||
| Q3 24 | — | $-7.2M | ||
| Q2 24 | $-4.8M | $-6.9M | ||
| Q1 24 | $-3.4M | $-8.5M |
自由现金流率BFRIDMRC
| Q4 25 | -13.9% | 10.0% | ||
| Q3 25 | -54.7% | -36.9% | ||
| Q2 25 | -33.7% | -61.0% | ||
| Q1 25 | -48.0% | -59.1% | ||
| Q4 24 | -8.1% | -49.1% | ||
| Q3 24 | — | -75.7% | ||
| Q2 24 | -60.8% | -66.1% | ||
| Q1 24 | -42.7% | -85.8% |
资本支出强度BFRIDMRC
| Q4 25 | 0.0% | 1.1% | ||
| Q3 25 | 0.0% | 2.9% | ||
| Q2 25 | 0.0% | 2.5% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.0% | 0.2% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.6% | 0.3% | ||
| Q1 24 | 0.7% | 1.1% |
现金转化率BFRIDMRC
| Q4 25 | -0.42× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BFRI
暂无分部数据
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
